Beijing Konruns Pharmaceutical Co.,Ltd.
SSE:603590.SS
31.3 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 189.978 | 230.204 | 345.245 | 599.082 | 1,346.669 | 1,802.969 | 1,689.824 | 542.729 | 214.038 | 34.671 | 39.93 | 112.836 |
| Short Term Investments
| 450.662 | 396.405 | 280.373 | 9.039 | 181.364 | 2.003 | -1.346 | -0.238 | -0.768 | -1.456 | -0.032 | -0.214 |
| Cash and Short Term Investments
| 640.64 | 626.609 | 625.619 | 608.121 | 1,528.032 | 1,804.973 | 1,689.824 | 542.729 | 214.038 | 34.671 | 39.93 | 112.836 |
| Net Receivables
| 291.218 | 318.389 | 336.608 | 244.379 | 241.475 | 273.839 | 231.341 | 78.592 | 25.979 | 8.548 | 2.686 | 1.159 |
| Inventory
| 72.383 | 48.467 | 36.992 | 47.021 | 33.942 | 14.254 | 9.625 | 17.215 | 20.434 | 13.461 | 14.486 | 10.255 |
| Other Current Assets
| 82.299 | 236.491 | 17.492 | 48.307 | 4.798 | 5.304 | 13.704 | 12.127 | 108.393 | 345.481 | 195.311 | 16.517 |
| Total Current Assets
| 1,086.54 | 1,229.956 | 1,016.712 | 947.829 | 1,808.247 | 2,098.369 | 1,944.494 | 650.664 | 368.845 | 402.161 | 261.272 | 139.295 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 426.295 | 414.544 | 440.144 | 406.891 | 328.624 | 348.892 | 369.671 | 384.365 | 241.845 | 201.998 | 182.784 | 179.815 |
| Goodwill
| 0 | 97.643 | 97.643 | 97.643 | 98.648 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 1,076.438 | 1,004.457 | 931.511 | 896.237 | 818.214 | 60.301 | 80.437 | 89.622 | 98.659 | 108.166 | 117.689 | 120.001 |
| Goodwill and Intangible Assets
| 1,076.438 | 1,102.099 | 1,029.154 | 993.88 | 916.862 | 60.301 | 80.437 | 89.622 | 98.659 | 108.166 | 117.689 | 120.001 |
| Long Term Investments
| 435.864 | 412.442 | 393.574 | 686.908 | 504.136 | 650.226 | 515.096 | 546.227 | 188.81 | 121.651 | 95.175 | 73.992 |
| Tax Assets
| 27.465 | 32.272 | 1.086 | 8.963 | 7.051 | 8.292 | 7.135 | 0.773 | 0.383 | 1.722 | 1.212 | 1.341 |
| Other Non-Current Assets
| 867.087 | 589.505 | 544.13 | 326.85 | 220.741 | 7.763 | 3.359 | 2.591 | 123.751 | 10.106 | 6.911 | 0.681 |
| Total Non-Current Assets
| 2,833.149 | 2,550.862 | 2,408.089 | 2,423.492 | 1,977.414 | 1,075.473 | 975.698 | 1,023.578 | 653.448 | 443.643 | 403.77 | 375.831 |
| Total Assets
| 3,919.689 | 3,780.818 | 3,424.801 | 3,371.32 | 3,785.661 | 3,173.843 | 2,920.192 | 1,674.241 | 1,022.293 | 845.804 | 665.042 | 515.127 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 73.569 | 82.967 | 48.475 | 46.738 | 108.384 | 229.614 | 231.079 | 102.871 | 26.179 | 49.106 | 48.237 | 36.326 |
| Short Term Debt
| 140.955 | 100.877 | 0 | 0 | 24.467 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 8.881 | 3.686 | 39.572 | 27.303 | 24.184 | 30.541 | 24.174 | 19.068 | 7.256 | 15.463 | 12.85 | 22.432 |
| Deferred Revenue
| 0 | 6.489 | 2.922 | 100.509 | 461.866 | 3.564 | 3.189 | 13.048 | 21.484 | 6.924 | 0 | 0 |
| Other Current Liabilities
| 129.278 | 129.368 | 81.394 | 79.525 | -23.877 | 69.942 | 70.309 | 79.953 | 59.09 | 39.585 | 57.962 | 101.864 |
| Total Current Liabilities
| 352.683 | 323.387 | 172.363 | 154.771 | 595.024 | 330.097 | 325.562 | 201.893 | 92.526 | 104.154 | 119.049 | 160.622 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 60.646 | 43.784 | 3.708 | 11.122 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 40.475 | 23.486 | 28.98 | 29.831 | 35.732 | 41.682 | 46.694 | 50.769 | 54.844 | 58.38 | 57.974 | 41.058 |
| Deferred Tax Liabilities Non-Current
| 39.72 | 27.782 | 29.625 | 45.018 | 70.968 | 74.066 | 67.221 | 66.268 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 140.842 | 95.051 | 62.312 | 85.972 | 106.7 | 115.748 | 113.916 | 117.037 | 54.844 | 58.38 | 57.974 | 41.058 |
| Total Liabilities
| 493.525 | 418.438 | 234.675 | 240.742 | 701.725 | 445.845 | 439.478 | 318.929 | 147.37 | 162.534 | 177.023 | 201.68 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 159.356 | 160 | 160 | 160 | 160 | 160 | 160 | 120 | 120 | 120 | 120 | 120 |
| Retained Earnings
| 1,964.593 | 1,970.025 | 1,850.892 | 1,796.349 | 1,703.546 | 1,475.321 | 1,287.274 | 1,040.483 | 561.666 | 389.346 | 213.556 | 55.256 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 79 | 62.999 | 80.399 | 244.569 | 110.855 | 51.619 | 64.433 | 62.861 | 43.527 | 0 | 0 |
| Other Total Stockholders Equity
| 1,020.462 | 850.918 | 852.017 | 852.017 | 970.225 | 1,092.677 | 1,061.822 | 193.257 | 193.257 | 173.923 | 183.377 | 157.467 |
| Total Shareholders Equity
| 3,144.412 | 3,059.942 | 2,925.908 | 2,888.765 | 3,078.34 | 2,727.998 | 2,480.714 | 1,355.312 | 874.923 | 683.27 | 488.019 | 312.017 |
| Total Equity
| 3,426.164 | 3,362.38 | 3,190.125 | 3,130.578 | 3,083.936 | 2,727.998 | 2,480.714 | 1,355.312 | 874.923 | 683.27 | 488.019 | 313.447 |
| Total Liabilities & Shareholders Equity
| 3,919.689 | 3,780.818 | 3,424.801 | 3,371.32 | 3,785.661 | 3,173.843 | 2,920.192 | 1,674.241 | 1,022.293 | 845.804 | 665.042 | 515.127 |